Related Experiment Video
Updated: Aug 15, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Future uses of ambulatory blood pressure monitoring: implications for therapy
1Tulane University, School of Medicine, New Orleans, LA 70112.
Insights
Ambulatory blood pressure monitoring helps assess treatments for heart disease. It guides therapies to manage 24-hour cardiovascular patterns, including heart rate and blood pressure, for better patient outcomes.
Area of Science:
- Cardiology
- Hypertension Management
- Circadian Rhythms
Background:
- Circadian cardiovascular patterns are crucial in ischemic heart disease and congestive heart failure.
- Understanding these patterns aids in optimizing treatment strategies.
- Abnormalities in circadian variation can exacerbate cardiac conditions.
Purpose of the Study:
- To evaluate the role of ambulatory blood pressure monitoring in assessing treatment effects on circadian cardiovascular patterns.
- To guide therapeutic interventions for ischemic heart disease and congestive heart failure based on 24-hour monitoring.
Main Methods:
- Utilizing ambulatory blood pressure monitoring to track cardiovascular patterns over a 24-hour cycle.
- Analyzing treatment efficacy in managing heart rate and blood pressure fluctuations.
- Observing circadian variation in patients with congestive heart failure.
Main Results:
- Beta-blocking agents effectively reduce heart rate and blood pressure in ischemic heart disease, including the morning surge.
- Vasodilating agents help reduce cardiac overload in congestive heart failure.
- Ambulatory monitoring confirms the effectiveness of drug interventions throughout the day and night.
Conclusions:
- Ambulatory blood pressure monitoring is vital for evaluating treatment impact on circadian cardiovascular rhythms.
- Therapies should target 24-hour heart rate and blood pressure control for ischemic heart disease.
- Managing cardiac overload through appropriate agents is essential for congestive heart failure patients with disrupted circadian patterns.
Abstract:
Ambulatory blood pressure monitoring can play a significant role in evaluating the effects of treatment on the circadian cardiovascular pattern of patients with ischemic heart disease and/or congestive heart disease. In ischemic heart disease, drug therapy should be designed to reduce heart rate and blood pressure throughout the 24-hour cycle, including the early morning surge. Beta-blocking agents appear to accomplish these reductions. In congestive heart failure, some patients maintain their circadian variation while others do not, leaving them without the normal period of cardiac rest during the nighttime hours. Therapy should be designed to reduce this cardiac overload, and vasodilating agents appear to accomplish this. Ambulatory monitoring is especially useful in monitoring the effectiveness of drug interventions throughout the 24-hour cycle.
Related Concept Videos
Equipments Used To Measure Blood Pressure
This invasive approach involves cannulating a peripheral artery. During each cardiac contraction, pressure generates mechanical motion within the catheter, transmitted through rigid, fluid-filled tubing to a transducer. This transducer converts mechanical motion into electrical signals displayed as waveforms on a monitor. An automatic flushing system prevents blood backflow. Due to the potential risk of unexpected arterial blood loss, this method is primarily used in intensive...
Errors occurring during blood pressure monitoring
Several factors...
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Pre-Procedural Guidelines for Assessing Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies

